Condition 1: Candida vaginitis. Condition 2: Candida vaginitis. Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere Candidiasis of vulva and vagina
Conditions
Interventions
Intervention 1: The patients in intervdntion group use 500 mg capsules of cinnamon three times a day (morning, noon, night) with clotrimazole vaginal cream1 %. One applicator of cream was used at be
Treatment - Drugs
The patients in intervdntion group use 500 mg capsules of cinnamon three times a day (morning, noon, night) with clotrimazole vaginal cream1 %. One applicator of cream was used at bed time for one w
The patients in placebo group use 400 mg capsules of starch powder three times a day(morning, noon, night) with clotrimazole vaginal cream1%.One applicator of cream use at bed time for one week
Sponsors
Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Ira
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Being Iranian; Being married ; Age between 15 or 45; Positive wet smear of vaginal discharge; Not being pregnancy, lactation and menopausal period; Not having any vaginal bleeding; Not having chorionic disease (diabetes, HIV,…); Women that hadn’t history of using antibiotic for 2 weeks before; Women that don’t use oral contraceptive pills; Not being overweight (Body Mass Index>29); Not having intercourse and vaginal douching during the last24 hours; Not using any antifungal drugs, for 2 weeks before the study; Not using vaginal cream for last 48 hours before the study; Not having allergy with herbal drugs Exclusion criteria: Having Trichomoniasis and bacterial vaginosis; Having allergy with herbal drugs; Having gastric ulcer
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment. Timepoint: Before treatment -3-4 days after the beginning of treatment - 14-days aftertreatment. Method of measurement: Information form.;Recurrence. Timepoint: 14 days after treatment and 8 weeks after treatment for the recurrence. Method of measurement: Wet smear and Culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Nahidi
Shahid Beheshtii University of Medical Sciences
Outcome results
None listed